Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Long-term safety Research status : Limited long-term human studies (newer peptides) Available data : Animal studies show excellent safety Human case reports very positive No known serious adverse effects Mitochondrial support theoretically beneficial Precautionary approach : Start with lower doses Monitor how you feel Consider periodic breaks Track health markers Contraindications Avoid if : Pregnancy or breastfeeding (no safety data) Active cancer (theoretical mitochondrial support to cancer cells) Severe cardiovascular disease (consult doctor) Consult doctor if : Chronic health conditions Taking multiple medications Mitochondrial disorders (ironically, may need medical supervision) Monitoring Recommended blood work : Baseline metabolic panel Glucose/HbA1c (if using for metabolic health) Liver/kidney function Retest at 12 weeks Frequency : Every 3-6 months during long-term use Biomarkers to track : Fasting glucose Insulin sensitivity markers Inflammatory markers (hs-CRP) Energy levels (subjective) Sourcing quality NAD+ peptides Quality critical for effectiveness and safety
Batch documentation: see Lab Reports / COAs and Quality & Testing
Results Timeline Explained. December 2025.
Tb-500 Mechanisms of Action Tb-500 works through an entirely different primary mechanism centered on actin binding
* Correspondence: Ying Liang, [email protected]
US$ 25.12
US$ 28.83
US$ 27.41
US$ 28.20
US$ 25.48
US$ 26.41
US$ 22.94